Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-14

Clinical Trial Update: Dual bNAb Treatment in Children [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a dual broadly neutralizing antibody (bNAb) treatment for HIV infection in children has completed enrollment and posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dual bNAb Cocktail

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-02-14